SC
AMED

Schubert & Co’s Amedisys AMED Stock Holding History

Schubert & Co’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11
Closed -$810 – 105
2023
Q1 		$810 Buy
11
+4
+57% +$346 ﹤0.01% 1283
2022
Q4 		$585 Sell
7
-7
-50% -$631 ﹤0.01% 1351
2022
Q3 		$1K Sell
14
-3
-18% -$358 ﹤0.01% 987
2022
Q2 		$2K Buy
17
+11
+183% +$1.41K ﹤0.01% 698
2022
Q1 		$1K Buy
6
+2
+50% +$299 ﹤0.01% 554
2021
Q4 		$1K Buy
+4
New +$643 ﹤0.01% 506

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Schubert & Co's AMED Position: Q2 2023 in Review

Schubert & Co sold out of Amedisys (AMED) in Q2 2023, closing a stake of 11 shares — an estimated $810 sold.

Schubert & Co first reported a position in AMED in Q4 2021 and held it in 6 quarters. The position peaked at $2K in Q2 2022. 301 funds tracked by Wall St. Rank hold AMED as of Q2 2023.

  • Schubert & Co reported no remaining Amedisys position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 11 Amedisys shares in Q2 2023, an estimated $810.
  • Schubert & Co first reported a position in Amedisys in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Amedisys position peaked at $2K in Q2 2022.
  • 301 funds tracked by Wall St. Rank held Amedisys as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.